Form 8-K - Current report:
SEC Accession No. 0001104659-23-108855
Filing Date
2023-10-12
Accepted
2023-10-12 17:04:15
Documents
19
Period of Report
2023-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328321d1_8k.htm   iXBRL 8-K 41584
2 EXHIBIT 1.1 tm2328321d1_ex1-1.htm EX-1.1 270320
3 EXHIBIT 4.1 tm2328321d1_ex4-1.htm EX-4.1 71041
4 EXHIBIT 4.2 tm2328321d1_ex4-2.htm EX-4.2 88995
5 EXHIBIT 5.1 tm2328321d1_ex5-1.htm EX-5.1 12730
6 EXHIBIT 99.1 tm2328321d1_ex99-1.htm EX-99.1 10270
7 GRAPHIC tm2328321d1_ex5-1img001.jpg GRAPHIC 4649
8 GRAPHIC tm2328321d1_ex99-1img001.jpg GRAPHIC 3093
  Complete submission text file 0001104659-23-108855.txt   803179

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA atxs-20231011.xsd EX-101.SCH 3018
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20231011_lab.xml EX-101.LAB 34240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20231011_pre.xml EX-101.PRE 22361
13 EXTRACTED XBRL INSTANCE DOCUMENT tm2328321d1_8k_htm.xml XML 3321
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 231323317
SIC: 2834 Pharmaceutical Preparations